Breast Cancer Research and Treatment

, Volume 49, Issue 1, pp 69–78 | Cite as

Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer

  • Kristina Dalberg
  • Anders Mattsson
  • Kerstin Sandelin
  • Lars E. Rutqvist


Introduction: The aims of the study were to assess the outcome among patients with early breast cancer operated on with wide local excision who developed a subsequent ipsilateral breast tumor recurrence, and to identify risk factors for uncontrolled local disease. Uncontrolled local disease (ULD) was defined as the appearance of clinically manifest invasive adenocarcinoma in the remaining breast or on the ipsilateral chest wall which could not be eradicated with salvage treatment during the period of follow-up (2–18 years). Patients and methods: Eighty-five patients in a cohort of 759 patients, treated for invasive Stage I–II breast cancer with breast-conserving surgery 1976–1985 in Stockholm, with a subsequent ipsilateral breast tumor recurrence (IBTR) were reviewed retrospectively. The majority of the patients were premenopausal (58%), node negative (72%), and had received postoperative radiotherapy (79%). Median follow-up time following breast-conserving surgery was 13 (9–19) years. Multivariate Cox's hazard regression was used in the statistical analysis to identify prognostic factors for ULD. Results: The majority (n = 61) of the IBTR's were located in the original tumor quadrant and showed the same histopathological features as the primary tumor. Salvage mastectomy (n = 65) or reexcision (n = 14) were performed in 79 (93%) of the patients. Twenty-one patients developed ULD. Five years following the diagnosis of IBTR the disease-free survival was 59%, the cumulative incidence for ULD was 24%, and for death in breast cancer 34%. In the cohort of 759 patients, patients who received radiotherapy following the primary breast-conserving surgery had 1% cumulative incidence of ULD following the diagnosis of IBTR compared to 4% among patients that received no postoperative radiotherapy. The cumulative incidence at 5 years of ULD following salvage mastectomy was 12% compared to 33% after salvage reexcision. Patients operated on with breast-conserving surgery with an original tumor size < 15 mm, who were treated with salvage mastectomy for IBTR, had in multivariate analysis the lowest relative risk for ULD. Adjuvant chemotherapy following IBTR treatment did not seem to improve local tumor control. Following the diagnosis of IBTR, 78% (n = 21) of the patients with ULD and/or regional recurrence (n = 27), died of a disseminated breast cancer in contrast to 10% (n = 6) among the remaining 58 patients. Conclusion: Uncontrolled local disease is an important outcome measure following breast-conserving surgery. In this cohort, salvage mastectomy provided a superior local control rate compared to salvage reexcision. A higher although not statistically significant rate of ULD was also seen in patients who had not received postoperative radiotherapy as part of their primary treatment.

breast cancer ipsilateral breast tumor recurrence prognosis uncontrolled local disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Conference NC: Treatment of early-stage breast cancer. JAMA 265: 391–397, 1991Google Scholar
  2. 2.
    Cedermark B, Askergren J, Alveryd A, Glas U, Kvarnström L, Somell A, Theve NO, Wallgren A: Breast-conserving treatment for breast cancer in Stockholm, Sweden, 1977 to 1981. Cancer 53(6): 1253–1255, 1984PubMedGoogle Scholar
  3. 3.
    Fisher B, Redmond C, Wolmark N, Wickerham L, Cronin W: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461, 1995CrossRefPubMedGoogle Scholar
  4. 4.
    Fowble BL, Solin LJ, Schultz DJ, Goodman RL: Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 21: 269–277, 1991PubMedGoogle Scholar
  5. 5.
    Kurtz JM, Amalric R, Brandone H et al.: Local recurrence after breast-conserving surgery and radiotherapy. Cancer 63: 1912–1917, 1989PubMedGoogle Scholar
  6. 6.
    Holmberg L, Liljegren G, Adami HO et al.: Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Natl Cancer Inst 82: 277–282, 1990PubMedGoogle Scholar
  7. 7.
    Osborne MP, Ormiston N, Harmer CL, McKinna JA, Baker J, Greening P: Breast conservation in the treatment of early breast cancer: A 20-year follow-up. Cancer 53: 349–355, 1984PubMedGoogle Scholar
  8. 8.
    Pezner RD, Wagman LD, Ben-Ezra J, Odom-Maryon T: Breast conservation therapy: local tumor control in patients with pathologically clear margins who receive 5000 cGy breast irradiation without local boost. Breast Cancer Res Treat 32: 261–267, 1994CrossRefPubMedGoogle Scholar
  9. 9.
    Spitalier JM, Gambarelli J, Brandone H et al.: Breast-conserving surgery with radiation therapy for operable mammary carcinoma: A 25-year experience. World J Surg 10: 1014–1020, 1986CrossRefPubMedGoogle Scholar
  10. 10.
    Veronesi U, Saccozzi R, Del Veccio M et al.: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305: 6–11, 1981PubMedGoogle Scholar
  11. 11.
    van Limbergen E, van den Boogaert W, van der Schueren E, Rijnders A: Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 8: 1–9, 1987PubMedGoogle Scholar
  12. 12.
    Veronest U, Banfi A, Salvadori B et al.: Breast conservation is the treament of choice in small breast cancer: Long-term results of a randomized trial. Eur J Cancer 26(6): 668–670, 1990PubMedGoogle Scholar
  13. 13.
    Vicini FA, Recht A, Abner A et al.: Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monographs 11: 33–39, 1992PubMedGoogle Scholar
  14. 14.
    van Dongen JA, Bartelink H, Fentimen IS et al.: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A(4/5): 801–805, 1992CrossRefPubMedGoogle Scholar
  15. 15.
    Fisher B, Redmond C, Poisson R et al.: Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320(13): 822–828, 1989PubMedGoogle Scholar
  16. 16.
    Clark RM, McCulloch PB, Levine MN et al.: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683–689, 1992PubMedGoogle Scholar
  17. 17.
    Veronesi U, Volerrani E, Luini A et al.: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 2(6): 671–673, 1990Google Scholar
  18. 18.
    Liljegren G, Holmberg L, Adami HO et al.: Sector resection with or without postoperative radiotherapy for stage I breast cancer. Five-year results of a randomized trial. J Natl Cancer Inst 86: 717–722, 1994PubMedGoogle Scholar
  19. 19.
    Veronesi U, Luini A, Del Vecchio M et al.: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328(22): 1587–1591, 1993CrossRefPubMedGoogle Scholar
  20. 20.
    Abner AL, Recht A, Eberlein T et al.: Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 11(1): 44–48, 1993PubMedGoogle Scholar
  21. 21.
    Fisher B, Anderson S, Fisher ER et al.: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 91: 338(8763): 327–331, 1991CrossRefPubMedGoogle Scholar
  22. 22.
    Haffty BG, Fischer D, Beinfield M, McKhann C: Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 21: 293–298, 1991PubMedGoogle Scholar
  23. 23.
    Kurtz JM, Spitalier JM, Amalric R et al.: The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 18: 87–93, 1990PubMedGoogle Scholar
  24. 24.
    Kurtz JM, Amalric R, Brandonc H, Ayme Y, Spitalier JM: Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer 61: 1969–1972, 1988PubMedGoogle Scholar
  25. 25.
    Osborne MP, Borgen PI, Wong GY, Rosen PP, McCormick B: Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy. Surgery, Gynecology & Obstetrics 174: 190–194, 1992Google Scholar
  26. 26.
    Stotter A, Atkinson EN, Fairston BA, McNeese M, Oswald MJ, Balch CM: Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 212(2): 166–172, 1990PubMedGoogle Scholar
  27. 27.
    Whelan T, Clark R, Roberts R, Levine M, Foster G et al.: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int J Radiat Oncol Biol Phys 30(1): 11–16, 1994PubMedGoogle Scholar
  28. 28.
    Kurtz J, Amalric R, Brandone H, Ayme Y, Spitalier J-M: Results of salvage surgery for mammary recurrence following breast conserving therapy. Ann Surg 207: 347–351, 1988PubMedGoogle Scholar
  29. 29.
    Barr LC, Brunt AM, Goodman AG. Phillips RH, Ellis H: Uncontrolled local recurrence after treatment of breast cancer with breast conservation. Cancer 64: 1203–1207, 1989PubMedGoogle Scholar
  30. 30.
    Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K: Breast conserving surgery for invasive breast cancer. Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43: 73–86, 1997CrossRefPubMedGoogle Scholar
  31. 31.
    Wrange Ö, Nordenskjöld B, Gustafsson JÖ: Cytosol estradiol receptor in human mammary carcinoma: an assay based on iso electric focusing in polyacrylamide gel. Anal Biochem 85(2): 461–475, 1978CrossRefPubMedGoogle Scholar
  32. 32.
    Wrange Ö, Humla S, Ramberg I, Gustafsson S, Nordenskjöld B, Gustafsson J-Ö: Progestin-receptor analysis in human breast cancer cytosol by isoelectric focusing in slabs of polyacrylamide gel. J Steroid Biochem 14: 141–148, 1981CrossRefPubMedGoogle Scholar
  33. 33.
    Rutqvist LE, Cedermark B, Glas U et al.: The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect. Breast Cancer Res Treat 10: 255–266, 1987CrossRefPubMedGoogle Scholar
  34. 34.
    Clayton D, Hills M: Statistical models in epidemiology. Oxford science publications. Oxford University Press, 1993Google Scholar
  35. 35.
    Preston DL, Lubin JH, Pierce DA, McConney DE: EPICURE: User's guide & command summary. Hirosoft International corp: Seattle, 1988–1993Google Scholar
  36. 36.
    Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL: Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radial Oncol Biol Phys 19: 833–842, 1990Google Scholar
  37. 37.
    Recht A, Schnitt SJ, Connolly JL et al.: Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16: 3–9, 1989PubMedGoogle Scholar
  38. 38.
    Rutqvist LE, Pettersson D, Johansson H: Adjuvant radiation therapy versus surgery in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 26: 104–110, 1993CrossRefPubMedGoogle Scholar
  39. 39.
    Mullen E, Deutsch, Bloomer W: Salvage radiotherapy for local failures of lumpectomy and breast irradiation. Radiother Oncol 42: 25–29, 1997CrossRefPubMedGoogle Scholar
  40. 40.
    Donegan WL, Perez-Mesa CM, Watson FR: A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 122: 529–540, 1966PubMedGoogle Scholar
  41. 41.
    Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy: Analysis of 716 consecutive patients. Cancer 41: 1170–1178, 1978PubMedGoogle Scholar
  42. 42.
    Veronesi U, Marubini E, Del Vecchio M, Manzari A et al.: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19–27, 1995PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Kristina Dalberg
    • 1
  • Anders Mattsson
    • 2
  • Kerstin Sandelin
    • 1
  • Lars E. Rutqvist
    • 2
  1. 1.Department of SurgeryKarolinska HospitalStockholmSweden
  2. 2.Department of Oncologic CentreKarolinska HospitalStockholmSweden

Personalised recommendations